title: Mycobacterium genavense-induced spindle cell pseudotumor in a pediatric hematopoietic stem cell transplant recipient: Case report and review of the literature.
abstract: We describe the first reported pediatric patient to our knowledge with a spindle cell pseudotumor caused by Mycobacterium genavense in a hematopoietic stem cell transplant recipient, and review the literature of such an entity in the transplant population.
authors.affiliation: Center for Pediatric Infectious Diseases, Cleveland Clinic Children's Hospital, Cleveland, OH, USA.
authors.forename: Ritika
authors.initials: R
authors.lastname: Coelho
authors.affiliation: Centers for Hematology - Oncology, Cleveland Clinic Children's Hospital, Cleveland, OH, USA.
authors.forename: Rabi
authors.initials: R
authors.lastname: Hanna
authors.affiliation: Centers for Hematology - Oncology, Cleveland Clinic Children's Hospital, Cleveland, OH, USA.
authors.forename: Aron
authors.initials: A
authors.lastname: Flagg
authors.affiliation: Departments of Pathology and Laboratory Medicine, Cleveland Clinic Children's Hospital, Cleveland, OH, USA.|Department of Pharmacy, Cleveland Clinic Children's Hospital, Cleveland, OH, USA.
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Stempak
authors.affiliation: Departments of Pathology and Laboratory Medicine, Cleveland Clinic Children's Hospital, Cleveland, OH, USA.
authors.forename: Sarah
authors.initials: S
authors.lastname: Ondrejka
authors.affiliation: Departments of Pathology and Laboratory Medicine, Cleveland Clinic Children's Hospital, Cleveland, OH, USA.
authors.forename: Gary W
authors.initials: GW
authors.lastname: Procop
authors.affiliation: Departments of Pathology and Laboratory Medicine, Cleveland Clinic Children's Hospital, Cleveland, OH, USA.
authors.forename: Susan
authors.initials: S
authors.lastname: Harrington
authors.affiliation: Department of Pharmacy, Cleveland Clinic Children's Hospital, Cleveland, OH, USA.
authors.forename: Anthony
authors.initials: A
authors.lastname: Zembillas
authors.affiliation: Department of Pharmacy, Cleveland Clinic Children's Hospital, Cleveland, OH, USA.
authors.forename: Karissa
authors.initials: K
authors.lastname: Kusick
authors.affiliation: Center for Pediatric Infectious Diseases, Cleveland Clinic Children's Hospital, Cleveland, OH, USA.
authors.forename: Blanca E
authors.initials: BE
authors.lastname: Gonzalez
mesh_terms: D000005:Abdomen; D000293:Adolescent; D000074323:Alemtuzumab; D019072:Antibiotic Prophylaxis; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000151:congenital / Q000601:surgery; D003967:Diarrhea / Q000601:surgery; D040181:Genetic Diseases, X-Linked / Q000601:surgery; D006084:Graft Rejection / Q000601:surgery; D006086:Graft vs Host Disease / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006644:Histiocytes / Q000382:microbiology*; D006801:Humans; D007154:Immune System Diseases / Q000151:congenital / Q000601:surgery; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008198:Lymph Nodes / Q000382:microbiology* / Q000473:pathology; D008297:Male; D008558:Melphalan / Q000009:adverse effects / Q000627:therapeutic use; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000627:therapeutic use; D009170:Nontuberculous Mycobacteria / Q000302:isolation & purification / Q000472:pathogenicity*; D017893:Photopheresis; D016133:Polymerase Chain Reaction; D019172:Transplantation Conditioning / Q000009:adverse effects* / Q000379:methods; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000904:Antibiotics, Antitubercular; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D000074323:Alemtuzumab; D016572:Cyclosporine; D014740:Vidarabine; D009173:Mycophenolic Acid; C024352:fludarabine; D008558:Melphalan
keywords: 
  Mycobacterium genavense
  ; hematopoietic stem cell transplant; pediatrics; spindle cell pseudotumor